Global and regional ischaemia in left ventricular hypertrophy reactive to hypertension

P Zarco1

  • 1Department of Cardiology, Universidad Complutense, Madrid, Spain.

European Heart Journal
|November 1, 1993
PubMed

Insights

Hypertension strains the heart, leading to left ventricular hypertrophy and increasing coronary atherosclerosis risk. A potential link between cardiological and endocrinological Syndrome X involves microvascular dysfunction and impaired nitric oxide production.

Area of Science:

  • Cardiology
  • Endocrinology
  • Vascular Biology

Background:

  • Hypertension increases cardiac afterload, causing left ventricular hypertrophy (LVH).
  • LVH is an independent risk factor for cardiovascular events.
  • Hypertension is associated with metabolic abnormalities, including endocrinological Syndrome X.

Purpose of the Study:

  • To explore the link between hypertension, cardiovascular risks, and metabolic syndrome.
  • To investigate the potential connection between cardiological Syndrome X and endocrinological Syndrome X.
  • To identify microvascular derangements, specifically endothelial dysfunction in nitric oxide (NO) production, as a unifying factor.

Main Methods:

  • Review of existing literature on hypertension, cardiac remodeling, and metabolic syndrome.
  • Analysis of the components of endocrinological Syndrome X (hyperinsulinaemia, insulin resistance, glucose intolerance, dyslipidaemia).
  • Examination of the role of endothelial dysfunction and nitric oxide (NO) bioavailability in cardiovascular pathology.

Main Results:

  • Hypertension contributes to LVH and coronary atherosclerosis.
  • Endocrinological Syndrome X involves a cluster of metabolic abnormalities and hypertension.
  • Microvascular derangements, particularly impaired NO production by the endothelium, may link cardiological and endocrinological Syndrome X.

Conclusions:

  • Hypertension poses significant risks to cardiac health through increased afterload and atherosclerosis.
  • Endocrinological Syndrome X represents a cluster of metabolic risks associated with hypertension.
  • Endothelial dysfunction and reduced nitric oxide (NO) production are implicated as a potential link between different manifestations of Syndrome X and cardiovascular disease.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...